Ginkgolides B and M from Ginkgo Biloba Extract alleviate AD via HIF-1α/PI3K-Akt modulation.
Investigating the Therapeutic Mechanism of Ginkgo Biloba Extract in Alzheimer's Disease via Integrated Network Pharmacology and Molecular Docking.
Abstract
Ginkgolides B and M, active compounds in Ginkgo Biloba Extract, alleviated synaptic protein damage and improved cognitive deficits in AD models by modulating HIF-1α and PI3K-Akt.